Alexandros Popotas

Dr. Alexandros Popotas

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Alexandros PopotasAlexandros Popotas
Alexandros Popotas
GCGeorges Jacques Casimir
Georges Jacques Casimir
FCFrancis Corazza
Francis Corazza
Nicolas LefèvreNicolas Lefèvre
Nicolas Lefèvre
An increasing number of studies have highlighted the existence of a sex-specific immune response, wherein men experience a worse prognosis in cases of acute inflammatory diseases. Initially, this sex-dependent inflammatory response was attributed to the influence of sex hormones. However, a growing body of evidence has shifted the focus toward the influence of chromosomes rather than sex hormones in shaping these inflammatory sex disparities. Notably, certain pattern recognition receptors, such as Toll-like receptors (TLRs), and their associated immune pathways have been implicated in driving the sex-specific immune response. These receptors are encoded by genes located on the X chromosome. TLRs are pivotal components of the innate immune system, playing crucial roles in responding to infectious diseases, including bacterial and viral pathogens, as well as trauma-related conditions. Importantly, the TLR-mediated inflammatory responses, as indicated by the production of specific proteins and cytokines, exhibit discernible sex-dependent patterns. In this review, we delve into the subject of sex bias in TLR activation and explore its clinical implications relatively to both the X chromosome and the hormonal environment. The overarching objective is to enhance our understanding of the fundamental mechanisms underlying these sex differences.

3 April 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
MDMaud Deny
Maud Deny
Alexandros PopotasAlexandros Popotas
Alexandros Popotas
LHLaurence Hanssens
Laurence Hanssens
Nicolas LefèvreNicolas Lefèvre
Nicolas Lefèvre
LNLuis Alexis Arroba Nuñez
Luis Alexis Arroba Nuñez
MCMustapha Chamekh
Mustapha Chamekh
Previous studies have reported sex disparity in cystic fibrosis (CF) disease, with females experiencing more pulmonary exacerbations and frequent microbial infections resulting in shorter survival expectancy. This concerns both pubertal and prepubertal females, which is in support to the prominent role of gene dosage rather than the hormonal status. The underlying mechanisms are still poorly understood. The X chromosome codes for a large number of micro-RNAs (miRNAs) that play a crucial role in the post-transcriptional regulation of several genes involved in various biological processes, including inflammation. However, their level of expression in CF males and females has not been sufficiently explored. In this study, we compared in male and female CF patients the expression of selected X-linked miRNAs involved in inflammatory processes. Cytokine and chemokine profiles were also evaluated at both protein and transcript levels and cross-analyzed with the miRNA expression levels. We observed increased expression of miR-223-3p, miR-106a-5p, miR-221-3p and miR-502-5p in CF patients compared to healthy controls. Interestingly, the overexpression of miR-221-3p was found to be significantly higher in CF girls than in CF boys and this correlates positively with IL-1β. Moreover, we found a trend toward lower expression in CF girls than in CF boys of suppressor of cytokine signaling 1 (SOCS1) and the ubiquitin-editing enzyme PDLIM2, two mRNA targets of miR-221-3p that are known to inhibit the NF-κB pathway. Collectively, this clinical study highlights a sex-bias in X-linked miR-221-3p expression in blood cells and its potential contribution to sustaining a higher inflammatory response in CF girls.

1 September 2024 in Viral Immunology
Verified
Journal Article
Closed access
NGNathalie Ghorra
Nathalie Ghorra
Alexandros PopotasAlexandros Popotas
Alexandros Popotas
TBTatiana Besse-Hammer
Tatiana Besse-Hammer
ARAnne Rogiers
Anne Rogiers
FCFrancis Corazza
Francis Corazza
CNCarole Nagant
Carole Nagant
The enduring impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its disease manifestation, COVID-19, on public health remains significant. Postacute sequelae of SARS-CoV-2 infection (PASC) affect a considerable number of patients, impairing their quality of life. While the role of the cytokine storm in acute COVID-19 is well established, its contribution to the pathophysiology of PASC is not fully understood. This study aimed to analyze the cytokine profile of patients with PASC following in vitro stimulation of Toll-like receptor (TLR) pathways, comparing them with a healthy control group. From October 2020 till March 2021, Brugmann University Hospital's clinical research unit included patients with PASC in the study. Whole blood samples were collected from 50 patients and 25 healthy volunteers. After in vitro stimulation under five different conditions, cytokine levels were measured using a multiplex method. Significantly decreased cytokine levels were observed in patients with PASC compared with healthy volunteers, particularly after TLR4 (interleukin [IL]-1α, IL-1β, IL-2, IL-10, interferon (IFN)α, IFNγ, IFNω, and tumor necrosis factor (TNF)α) and TLR7/8 (IL-1α, IL-1β, IFNα, IFNω, IFNγ, and TNFα) pathway stimulation. Principal component analysis identified two distinct clusters, suggesting a likely dysregulation of immunity involving TLR4 and TLR7/8 pathways in patients with PASC. Our study suggests that TLR4 and TLR7/8 pathways play a role in the pathophysiology of PASC. Continuous basal activation of immunity could explain the high basal concentrations of cytokines described in these patients and the decreased amplitude of response of these signaling pathways following specific stimulation.

13 July 2026 in Cells
Verified
Journal Article
Open access
PDF file
Alexandros PopotasAlexandros Popotas
Alexandros Popotas
ADAnne Delbaere
Anne Delbaere
GCGeorges Jacques Casimir
Georges Jacques Casimir
FCFrancis Corazza
Francis Corazza
VMViviane de maertelaer
Viviane de maertelaer
Nicolas LefèvreNicolas Lefèvre
Nicolas Lefèvre
Research has shown a sex-specific immune response, with males having a worse prognosis in acute inflammatory diseases. While these disparities were initially attributed to sex hormones, increasing evidence points to a predominant role for X-linked genetic factors. Toll-like receptors and several components of their signaling pathway are encoded on the X chromosome and may contribute to these differences. We investigated whether increase in circulating oestradiol influences TLR-dependent immune response. Sixteen women undergoing controlled ovarian hyperstimulation for in vitro fertilisation were studied. Whole blood collected before treatment, during stimulation and at ovulation triggering was stimulated with ligands targeting TLR2/6, TLR1/2, TLR4 and TLR7/8. TLR2, TLR4 and CD99 expression, intracellular phosphorylated NF-κB p65, ERK1/2 and p38 MAPK, and cytokine production were assessed. Oestradiol levels increased markedly during treatment (48.1 to 1819.5 pg/mL; p < 0.001). Despite this rise, no or minimal impact on TLR2/4 and CD99 expression, intracellular signalling or cytokine release was detected. Only IL-6 and IL-10 in response to TLR2/6 stimulation increased significantly, with IL-6 positively associated with oestradiol variation. These findings indicate that oestradiol exerts a limited influence on TLR-dependent immune responses, supporting our view that sex-based immune differences are driven primarily by genetic rather than hormonal factors.